These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 27354596)
1. A Cytokine Cocktail Augments the Efficacy of Adoptive NK-92 Cell Therapy Against Mouse Xenografts of Human Cancer. Samara P; Skopeliti M; Tsiatas ML; Georgaki S; Gouloumis C; Voelter W; Dimopoulos AM; Bamias A; Tsitsilonis OE Anticancer Res; 2016 Jul; 36(7):3373-82. PubMed ID: 27354596 [TBL] [Abstract][Full Text] [Related]
2. Growth and activation of natural killer cells ex vivo from children with neuroblastoma for adoptive cell therapy. Liu Y; Wu HW; Sheard MA; Sposto R; Somanchi SS; Cooper LJ; Lee DA; Seeger RC Clin Cancer Res; 2013 Apr; 19(8):2132-43. PubMed ID: 23378384 [TBL] [Abstract][Full Text] [Related]
3. Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy. Ayello J; Hochberg J; Flower A; Chu Y; Baxi LV; Quish W; van de Ven C; Cairo MS Exp Hematol; 2017 Feb; 46():38-47. PubMed ID: 27765614 [TBL] [Abstract][Full Text] [Related]
4. Induction of anti-tumour lymphocytes in cancer patients after brief exposure to supernatants from cultures of anti-CD3-stimulated allogeneic lymphocytes. Baxevanis CN; Tsiatas ML; Cacoullos NT; Spanakos G; Liacos C; Missitzis I; Papadhimitriou SI; Papamichail M Br J Cancer; 1997; 76(8):1072-80. PubMed ID: 9376269 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of allogeneic CD3AK cells on transplanted human renal cell cancer in mice with severe combined immune deficiency. Ge L; Shan Z; Han Q; Zhang N; Zhao Y J BUON; 2016; 21(2):399-406. PubMed ID: 27273950 [TBL] [Abstract][Full Text] [Related]
6. NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. Lakshmikanth T; Burke S; Ali TH; Kimpfler S; Ursini F; Ruggeri L; Capanni M; Umansky V; Paschen A; Sucker A; Pende D; Groh V; Biassoni R; Höglund P; Kato M; Shibuya K; Schadendorf D; Anichini A; Ferrone S; Velardi A; Kärre K; Shibuya A; Carbone E; Colucci F J Clin Invest; 2009 May; 119(5):1251-63. PubMed ID: 19349689 [TBL] [Abstract][Full Text] [Related]
7. PD1 blockade enhances cytotoxicity of in vitro expanded natural killer cells towards myeloma cells. Guo Y; Feng X; Jiang Y; Shi X; Xing X; Liu X; Li N; Fadeel B; Zheng C Oncotarget; 2016 Jul; 7(30):48360-48374. PubMed ID: 27356741 [TBL] [Abstract][Full Text] [Related]
8. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells. Rabinowich H; Vitolo D; Altarac S; Herberman RB; Whiteside TL J Immunol; 1992 Jul; 149(1):340-9. PubMed ID: 1535088 [TBL] [Abstract][Full Text] [Related]
9. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy. Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292 [TBL] [Abstract][Full Text] [Related]
10. Guo X; Mahlakõiv T; Ye Q; Somanchi S; He S; Rana H; DiFiglia A; Gleason J; van der Touw W; Hariri R; Zhang X J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33741730 [TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of recombinant human prolactin in human adenocarcinoma-bearing SCID mice with human NK cell xenograft. Zhang J; Sun R; Wei H; Tian Z Int Immunopharmacol; 2005 Feb; 5(2):417-25. PubMed ID: 15652770 [TBL] [Abstract][Full Text] [Related]
12. Effect of human natural killer cells on the metastatic growth of human melanoma xenografts in mice with severe combined immunodeficiency. Hill LL; Perussia B; McCue PA; Korngold R Cancer Res; 1994 Feb; 54(3):763-70. PubMed ID: 8306339 [TBL] [Abstract][Full Text] [Related]
13. Expansion and homing of adoptively transferred human natural killer cells in immunodeficient mice varies with product preparation and in vivo cytokine administration: implications for clinical therapy. Miller JS; Rooney CM; Curtsinger J; McElmurry R; McCullar V; Verneris MR; Lapteva N; McKenna D; Wagner JE; Blazar BR; Tolar J Biol Blood Marrow Transplant; 2014 Aug; 20(8):1252-7. PubMed ID: 24816582 [TBL] [Abstract][Full Text] [Related]
14. Mechanistic analysis of the antitumor efficacy of human natural killer cells against breast cancer cells. Kajitani K; Tanaka Y; Arihiro K; Kataoka T; Ohdan H Breast Cancer Res Treat; 2012 Jul; 134(1):139-55. PubMed ID: 22261932 [TBL] [Abstract][Full Text] [Related]
15. Anti-ovarian tumor response of donor peripheral blood mononuclear cells is due to infiltrating cytotoxic NK cells. Pandey V; Oyer JL; Igarashi RY; Gitto SB; Copik AJ; Altomare DA Oncotarget; 2016 Feb; 7(6):7318-28. PubMed ID: 26802025 [TBL] [Abstract][Full Text] [Related]
16. [Specific immune cell therapy against ovarian cancer in vivo and in vitro]. Chang XH; Cheng HY; Cheng YX; Ye X; Guo HF; Fu TY; Zhang L; Zhang G; Cui H Ai Zheng; 2008 Dec; 27(12):1244-50. PubMed ID: 19079987 [TBL] [Abstract][Full Text] [Related]
17. Large-scale expansion of CD3(+)CD56(+) lymphocytes capable of lysing autologous tumor cells with cytokine-rich supernatants. Gritzapis AD; Dimitroulopoulos D; Paraskevas E; Baxevanis CN; Papamichail M Cancer Immunol Immunother; 2002 Oct; 51(8):440-8. PubMed ID: 12202905 [TBL] [Abstract][Full Text] [Related]
18. Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells. Ferreira-Teixeira M; Paiva-Oliveira D; Parada B; Alves V; Sousa V; Chijioke O; Münz C; Reis F; Rodrigues-Santos P; Gomes C BMC Med; 2016 Oct; 14(1):163. PubMed ID: 27769244 [TBL] [Abstract][Full Text] [Related]
19. Induced Pluripotent Stem Cell-conditioned Medium Suppressed Melanoma Tumorigenicity Through the Enhancement of Natural-Killer Cellular Immunity. Hsieh CT; Luo YH; Chien CS; Wu CH; Tseng PC; Chiou SH; Lee YC; Whang-Peng J; Chen YM J Immunother; 2016 May; 39(4):153-9. PubMed ID: 27023059 [TBL] [Abstract][Full Text] [Related]
20. Establishment, characterization, and successful adaptive therapy against human tumors of NKG cell, a new human NK cell line. Cheng M; Ma J; Chen Y; Zhang J; Zhao W; Zhang J; Wei H; Ling B; Sun R; Tian Z Cell Transplant; 2011; 20(11-12):1731-46. PubMed ID: 21669033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]